Follow the people · Insider
Grant Pickering
Grant Pickering files insider transactions with the SEC as a chief executive officer of Vaxcyte (PCVX). We hold 3 disclosed purchases and sales filed since 22 December 2020, 3 of them in the last 90 days.
- Files forPCVX
- Disclosed buys and sells3 in all, 3 in the last 90 days
- Last disclosure2 September 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 21 December 2020 — 2 September 2026Chief Executive Officer · Vaxcyte (PCVX)330 Form 4 lines · source: SEC Form 4
- Filed 9 April 2026 — 23 June 2026Director · LeonaBio (LONA)2 Form 4 lines · source: SEC Form 4
- Filed 27 January 2022 — 30 May 2025Director · Athira Pharma (ATHA)7 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 2,862 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- had shares withheld for tax on 3,427 shares of VaxcyteSEC Form 42 September 2026Common Stock · traded 2 September 2026 · filed 2 September 2026
- exercised options over 16,198 shares of VaxcyteSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
- ▼ sold on the open market 11,783 shares of VaxcyteSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
- ▼ sold on the open market 4,415 shares of VaxcyteSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
- ▼ sold on the open market 756 shares of VaxcyteSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
- ▼ sold on the open market 244 shares of VaxcyteSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
- ▼ sold on the open market 622 shares of VaxcyteSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
- ▼ sold on the open market 378 shares of VaxcyteSEC Form 428 July 2026Common Stock · traded 27 July 2026 · filed 28 July 2026
- exercised options over 16,198 shares of Vaxcyte (a derivative holding)SEC Form 428 July 2026Stock Option (right to buy) · traded 27 July 2026 · filed 28 July 2026
- ▼ sold on the open market 6,683 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 9,137 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 6,417 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 312 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 356 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 332 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 207 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 602 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- ▼ sold on the open market 191 shares of VaxcyteSEC Form 426 June 2026Common Stock · traded 26 June 2026 · filed 26 June 2026
- was granted 28,000 shares of LeonaBio (a derivative holding)SEC Form 424 June 2026Stock Option (Right to Buy) · traded 23 June 2026 · filed 24 June 2026
- exercised options over 225 shares of VaxcyteSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- ▼ sold on the open market 225 shares of VaxcyteSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- ▼ sold on the open market 22,236 shares of VaxcyteSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- ▼ sold on the open market 1,000 shares of VaxcyteSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- ▼ sold on the open market 1,000 shares of VaxcyteSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- exercised options over 225 shares of Vaxcyte (a derivative holding)SEC Form 418 June 2026Stock Option (right to buy) · traded 18 June 2026 · filed 18 June 2026
- was granted 28,000 shares of LeonaBio (a derivative holding)SEC Form 413 April 2026Stock Option (Right to Buy) · traded 9 April 2026 · filed 13 April 2026
- had shares withheld for tax on 3,685 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- had shares withheld for tax on 3,685 shares of VaxcyteSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- was granted 105,110 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,863 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,531 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- was granted 175,698 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- was granted 175,698 shares of Vaxcyte (a derivative holding)SEC Form 42 March 2026Stock Option (right to buy) · traded 26 February 2026 · filed 2 March 2026
- was granted 105,110 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,863 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 28 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,531 shares of VaxcyteSEC Form 42 March 2026Common Stock · traded 2 March 2026 · filed 2 March 2026
- gave away 100,000 shares of VaxcyteSEC Form 416 January 2026Common Stock · traded 14 January 2026 · filed 16 January 2026
- gave away 100,000 shares of VaxcyteSEC Form 416 January 2026Common Stock · traded 14 January 2026 · filed 16 January 2026
- had shares withheld for tax on 7,356 shares of VaxcyteSEC Form 410 September 2025Common Stock · traded 8 September 2025 · filed 10 September 2025
- had shares withheld for tax on 2,857 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 4,563 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 3,420 shares of VaxcyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- was granted 20,900 shares of Athira Pharma (a derivative holding)SEC Form 43 June 2025Stock Option (Right to Buy) · traded 30 May 2025 · filed 3 June 2025
- exercised options over 15,781 shares of Vaxcyte (a derivative holding)SEC Form 47 April 2025Stock Option (right to buy) · traded 4 April 2025 · filed 7 April 2025
- exercised options over 4,752 shares of Vaxcyte (a derivative holding)SEC Form 47 April 2025Stock Option (right to buy) · traded 4 April 2025 · filed 7 April 2025
- exercised options over 15,781 shares of VaxcyteSEC Form 47 April 2025Common Stock · traded 4 April 2025 · filed 7 April 2025
- exercised options over 4,752 shares of VaxcyteSEC Form 47 April 2025Common Stock · traded 4 April 2025 · filed 7 April 2025
- was granted 193,431 shares of Vaxcyte (a derivative holding)SEC Form 43 March 2025Stock Option (right to buy) · traded 27 February 2025 · filed 3 March 2025
- was granted 57,938 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 27 March 2025 · filed 3 March 2025
- had shares withheld for tax on 2,013 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 28 February 2025 · filed 3 March 2025
- had shares withheld for tax on 7,984 shares of VaxcyteSEC Form 43 March 2025Common Stock · traded 3 March 2025 · filed 3 March 2025
- ▼ sold on the open market 961 shares of VaxcyteSEC Form 410 December 2024Common Stock · traded 9 December 2024 · filed 10 December 2024
- ▼ sold on the open market 222 shares of VaxcyteSEC Form 410 December 2024Common Stock · traded 9 December 2024 · filed 10 December 2024
- ▼ sold on the open market 1,029 shares of VaxcyteSEC Form 410 December 2024Common Stock · traded 9 December 2024 · filed 10 December 2024
- ▼ sold on the open market 154 shares of VaxcyteSEC Form 410 December 2024Common Stock · traded 9 December 2024 · filed 10 December 2024
- ▼ sold on the open market 11,349 shares of VaxcyteSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- ▼ sold on the open market 1,409 shares of VaxcyteSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- ▼ sold on the open market 2,242 shares of VaxcyteSEC Form 43 December 2024Common Stock · traded 2 December 2024 · filed 3 December 2024
- gave away 710 shares of VaxcyteSEC Form 419 November 2024Common Stock · traded 18 November 2024 · filed 19 November 2024
- exercised options over 663 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Stock Option (right to buy) · traded 7 November 2024 · filed 8 November 2024
- exercised options over 14,129 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Stock Option (right to buy) · traded 7 November 2024 · filed 8 November 2024
- exercised options over 16,000 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Stock Option (right to buy) · traded 7 November 2024 · filed 8 November 2024
- was granted 197,784 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Performance Stock Option (right to buy) · traded 7 November 2024 · filed 8 November 2024
- was granted 80,625 shares of Vaxcyte (a derivative holding)SEC Form 48 November 2024Performance Restricted Stock Units · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 227 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 463 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 377 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 116 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 281 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 363 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 434 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 105 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- exercised options over 663 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- exercised options over 14,129 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- exercised options over 16,000 shares of VaxcyteSEC Form 48 November 2024Common Stock · traded 7 November 2024 · filed 8 November 2024
- ▼ sold on the open market 9,955 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- ▼ sold on the open market 3,312 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- ▼ sold on the open market 1,733 shares of VaxcyteSEC Form 44 November 2024Common Stock · traded 1 November 2024 · filed 4 November 2024
- ▼ sold on the open market 310 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- ▼ sold on the open market 887 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- ▼ sold on the open market 2,113 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- ▼ sold on the open market 239 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- ▼ sold on the open market 356 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- ▼ sold on the open market 807 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- ▼ sold on the open market 1,849 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- ▼ sold on the open market 537 shares of VaxcyteSEC Form 48 October 2024Common Stock · traded 7 October 2024 · filed 8 October 2024
- exercised options over 20,000 shares of Vaxcyte (a derivative holding)SEC Form 43 October 2024Stock Option (right to buy) · traded 1 October 2024 · filed 3 October 2024
- exercised options over 20,000 shares of Vaxcyte (a derivative holding)SEC Form 43 October 2024Stock Option (right to buy) · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 3,624 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 7,088 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 4,288 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- exercised options over 20,000 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 4,305 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 9,429 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 6,266 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- exercised options over 20,000 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 4,899 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 9,627 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- ▼ sold on the open market 5,474 shares of VaxcyteSEC Form 43 October 2024Common Stock · traded 1 October 2024 · filed 3 October 2024
- had shares withheld for tax on 13,669 shares of VaxcyteSEC Form 45 September 2024Common Stock · traded 3 September 2024 · filed 5 September 2024
- exercised options over 15,000 shares of Vaxcyte (a derivative holding)SEC Form 426 August 2024Stock Option (right to buy) · traded 23 August 2024 · filed 26 August 2024
- exercised options over 15,000 shares of VaxcyteSEC Form 426 August 2024Common Stock · traded 23 August 2024 · filed 26 August 2024
- ▼ sold on the open market 6,686 shares of VaxcyteSEC Form 426 August 2024Common Stock · traded 23 August 2024 · filed 26 August 2024
- ▼ sold on the open market 8,314 shares of VaxcyteSEC Form 426 August 2024Common Stock · traded 23 August 2024 · filed 26 August 2024
- ▼ sold on the open market 1,308 shares of VaxcyteSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- ▼ sold on the open market 1,308 shares of VaxcyteSEC Form 45 August 2024Common Stock · traded 1 August 2024 · filed 5 August 2024
- exercised options over 15,000 shares of Vaxcyte (a derivative holding)SEC Form 424 July 2024Stock Option (right to buy) · traded 23 July 2024 · filed 24 July 2024
- exercised options over 15,000 shares of VaxcyteSEC Form 424 July 2024Common Stock · traded 23 July 2024 · filed 24 July 2024
- ▼ sold on the open market 5,718 shares of VaxcyteSEC Form 424 July 2024Common Stock · traded 23 July 2024 · filed 24 July 2024
- ▼ sold on the open market 9,282 shares of VaxcyteSEC Form 424 July 2024Common Stock · traded 23 July 2024 · filed 24 July 2024
- ▼ sold on the open market 674 shares of VaxcyteSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 634 shares of VaxcyteSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 751 shares of VaxcyteSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- ▼ sold on the open market 557 shares of VaxcyteSEC Form 42 July 2024Common Stock · traded 1 July 2024 · filed 2 July 2024
- exercised options over 15,000 shares of Vaxcyte (a derivative holding)SEC Form 425 June 2024Stock Option (right to buy) · traded 24 June 2024 · filed 25 June 2024
- exercised options over 15,000 shares of VaxcyteSEC Form 425 June 2024Common Stock · traded 24 June 2024 · filed 25 June 2024
- ▼ sold on the open market 10,341 shares of VaxcyteSEC Form 425 June 2024Common Stock · traded 24 June 2024 · filed 25 June 2024
- ▼ sold on the open market 4,471 shares of VaxcyteSEC Form 425 June 2024Common Stock · traded 24 June 2024 · filed 25 June 2024
- ▼ sold on the open market 188 shares of VaxcyteSEC Form 425 June 2024Common Stock · traded 24 June 2024 · filed 25 June 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.